coronary stents market size, coronary stents market trend, coronary stents market forecast, coronary stents market demand, us coronary stents market, coronary stents industry
What is the current size and annual growth rate of the coronary stents market?
The coronary stents market size has grown strongly in recent years. It will grow from $11.06 billion in 2024 to $12.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to growing preference for minimally invasive procedures, expansion of healthcare access in emerging markets, rising healthcare expenditure, increase in percutaneous coronary interventions, growing number of cardiologists.
The coronary stents market size is expected to see strong growth in the next few years. It will grow to $16.5 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing incidence of cardiovascular diseases, aging population, rising awareness about cardiovascular health, supportive government programs and funding, growing incidence of lifestyle diseases. Major trends in the forecast period include innovations in stent technology, innovations in imaging technologies, strategic collaborations and partnerships, innovations in stent materials, technological integration with digital health.
Get Your Free Sample of The Global Coronary Stents Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp
What have been the primary factors driving the coronary stents market’s growth?
The rising prevalence of cardiovascular diseases (CVDs) is expected to propel the growth of the coronary stent market going forward. Cardiovascular diseases are a group of disorders of the heart and blood vessels, including conditions such as coronary artery disease, heart failure, stroke, and hypertension. Cardiovascular diseases are rising due to factors like an aging population, an increased prevalence of risk factors such as obesity, diabetes, sedentary lifestyles, a poor diet, and stress. A coronary stent is required for cardiovascular diseases to open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For instance, in August 2022, a report by the American College of Cardiology, a US-based non-profit medical association, projected significant increases in cardiovascular risk factors in the U.S. from 2025 to 2060. Diabetes is expected to rise by 39.3% to 55 million people, dyslipidemia by 27.6% to 126 million, hypertension by 25.1% to 162 million, and obesity by 18.3% to 126 million. The most significant increases in cardiovascular diseases are projected for stroke (33.8% increase to 15 million) and heart failure (33.4% increase to 13 million), followed by ischemic heart disease (30.7% increase to 29 million) and heart attacks (16.9% increase to 16 million). Therefore, the rising prevalence of cardiovascular diseases (CVDs) is driving the growth of the coronary stent market.
What are the key segments within the coronary stents market?
The coronary stents market covered in this report is segmented –
1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents
2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies
3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer
4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents
5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
Subsegments:
1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents
2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents
3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents
4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents
5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents
6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents
7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents
8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents
9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report
Which key players are shaping the coronary stents market?
Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation
How will emerging trends drive the coronary stents market throughout the forecast period?
Major companies operating in the coronary stent market are developing innovative products, such as drug-eluting stents, to reduce the need for repeat procedures compared to bare-metal stents. Drug-eluting stents are specialized coronary stents coated with medication designed to prevent the re-narrowing of arteries by releasing drugs gradually over time. For instance, in May 2024, Abbott, a US-based healthcare company, launched the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent stands out due to its enhanced design, new delivery system, and unique size options, specifically engineered to address challenging cases. It retains the specialized coating that reduces the risk of artery re-blockage, consistent with other XIENCE stents. This stent benefits from an exceptional safety record, backed by over 120 clinical trials involving more than 120,000 patients.
How do regional factors impact the coronary stents market, and which region is the largest contributor?
North America was the largest region in the coronary stents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Coronary Stents Market Report 2025 Offer?
The coronary stents market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Coronary stents are small, expandable tubes used to open up narrowed or blocked coronary arteries, which supply blood to the heart muscle. These devices are typically made of metal mesh and are placed during a procedure called percutaneous coronary intervention (PCI), often referred to as angioplasty. The stent is inserted into the artery on a balloon catheter and expanded at the site of the blockage to restore proper blood flow.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18325
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
